Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

VOLUME 17 , ISSUE 4 ( October-December, 2023 ) > List of Articles


The Genetic Correlation of Ultrasonic Uterine Fibroid Mapping

Hisham Arab

Keywords : Epigenetic, Genetic, Mapping, Ultrasound, Uterine fibroids

Citation Information : Arab H. The Genetic Correlation of Ultrasonic Uterine Fibroid Mapping. Donald School J Ultrasound Obstet Gynecol 2023; 17 (4):290-294.

DOI: 10.5005/jp-journals-10009-1999

License: CC BY-NC 4.0

Published Online: 28-12-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Uterine fibroids (UFs) or leiomyomas (LM) are common benign neoplasms of the uterus. UFs have many complications and can negatively affect the women's quality of life, and their management can get interventional. This review discusses the epidemiology, etiology, pathogenesis, and genetic origin of UFs as well as the contributing epigenetic factors to their development. We correlated some of the driving genetic factors of fibroids with their presentation or location on ultrasound clinically.

  1. Devereaux KA, Schoolmeester JK. Smooth muscle tumors of the female genital tract. Surg Pathol Clin 2019;12(2):397–455. DOI: 10.1016/j.path.2019.02.004
  2. Gomez E, Nguyen MT, Fursevich D, et al. MRI-based pictorial review of the FIGO classification system for uterine fibroids. Abdom Radiol (NY) 2021;46(5):2146–2155. DOI: 10.1007/s00261-020-02882-z
  3. Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet 2020;149(1):3–9. DOI: 10.1002/ijgo.13102
  4. Cheng LC, Li HY, Gong QQ, et al. Global, regional, and national burden of uterine fibroids in the last 30 years: estimates from the 1990 to 2019 global burden of disease study. Front Med (Lausanne) 2022;9:1003605. DOI: 10.3389/fmed.2022.1003605
  5. Thanasa E, Thanasa A, Kamaretsos E, et al. Large cervical leiomyoma of the uterus: a rare cause of chronic pelvic pain associated with obstructive uropathy and renal dysfunction: a case report. Cureus 2023;15(1):e33387. DOI: 10.7759/cureus.33387
  6. De La Cruz MS, Buchanan EM. Uterine fibroids: diagnosis and treatment. Am Fam Physician 2017;95(2):100–107.
  7. Lou Z, Huang Y, Li S, et al. Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990-2019: an age-period-cohort analysis for the global burden of disease 2019 study. BMC Public Health 2023;23(1):916. DOI: 10.1186/s12889-023-15765-x
  8. Rubisz P, Hirnle L, Kobierzycki C. The immunohistochemical expression of MCM-3, -5, and -7 proteins in the uterine fibroids. Curr Issues Mol Biol 2021;43(2):802–817. DOI: 10.3390/cimb43020058
  9. Boyd CA, Riall TS. Unexpected gynecologic findings during abdominal surgery. Curr Probl Surg 2012;49(4):195–251. DOI: 10.1067/j.cpsurg.2011.12.002
  10. Stewart EA, Laughlin-Tommaso SK, Catherino WH, et al. Uterine fibroids. Nat Rev Dis Primers 2016;2:16043. DOI: 10.1038/nrdp.2016.43
  11. Moroni RM, Vieira CS, Ferriani RA, et al. Presentation and treatment of uterine leiomyoma in adolescence: a systematic review. BMC women's health 2015;15:4. DOI: 10.1186/s12905-015-0162-9
  12. Yang Q, Mas A, Diamond MP, et al. The mechanism and function of epigenetics in uterine leiomyoma development. Reprod Sci 2016;23(2):163–175. DOI: 10.1177/1933719115584449
  13. Ciebiera, M, Włodarczyk M, Ciebiera M, et al. Vitamin D and uterine fibroids—review of the literature and novel concepts. Int J Mol Sci 2018;19(7):2051. DOI: 10.3390/ijms19072051
  14. Halder SK, Osteen KG, Al-Hendy A. Vitamin D3 inhibits matrix metalloproteinase-2 and -9 expression and activities in human uterine fibroid cells. Hum Reprod 2013;28(9):2407–2416. DOI: 10.1093/humrep/det265
  15. Alauddin N. A clinical study on uterine fibroids. Int J Acad Med Pharm 2023;5(1):222–224. DOI: 10.47009/jamp.2023.5.1.46
  16. Munro MG, Critchley HO, Broder MS, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011;113(1):3–13. DOI: 10.1016/j.ijgo.2010.11.011
  17. Yang Q, Ciebiera M, Bariani MV, et al. Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment. Endocr Rev 2022;43(4):678–719. DOI: 10.1210/endrev/bnab039
  18. Baranov VS, Ivaschenko TE, Yarmolinskaya MI. Comparative systems genetics view of endometriosis and uterine leiomyoma: two sides of the same coin? Syst Biol Reprod Med 2016;62(2):93–105. DOI: 10.3109/19396368.2015.1123325
  19. Baranov VS, Osinovskaya NS, Yarmolinskaya MI. Pathogenomics of uterine fibroids development. Int J Mol Sci 2019;20(24):6151. DOI: 10.3390/ijms20246151
  20. Mehine M, Kaasinen E, Heinonen HR, et al. Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers. Proc Natl Acad Sci USA 2016;113(5):1315–1320. DOI: 10.1073/pnas.1518752113
  21. Xie J, Ubango J, Ban Y, et al. Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations. Genes Chromosomes Cancer 2018;57(10):485–494. DOI: 10.1002/gcc.22643
  22. Omar M, Laknaur A, Al-Hendy A, et al. Myometrial progesterone hyper-responsiveness associated with increased risk of human uterine fibroids. BMC womens Health 2019;19(1):92. DOI: 10.1186/s12905-019-0795-1
  23. Toprani SM, Kelkar Mane V. Role of DNA damage and repair mechanisms in uterine fibroid/leiomyomas: a review. Biol Reprod 2021;104(1):58–70. DOI: 10.1093/biolre/ioaa157
  24. de Oliveira E, de Aquino Castro R, Gomes MT, et al. The catechol-O-methyltransferase (COMT) gene polymorphism and prevalence of uterine fibroids. Maturitas 2008;60 (3-4):235–238. DOI: 10.1016/j.maturitas.2008.07.001
  25. Yu L, Liu J, Yan Y, et al. “Metalloestrogenic” effects of cadmium downstream of G protein-coupled estrogen receptor and mitogen-activated protein kinase pathways in human uterine fibroid cells. Arch Toxicol 2021;95(6):1995–2006. DOI: 10.1007/s00204-021-03033-z
  26. Ciebiera M, Włodarczyk M, Wrzosek M, et al. Role of transforming growth factor β in uterine fibroid biology. Int J Mol Sci 2017;18(11):2435. DOI: 10.3390/ijms18112435
  27. Oliveto S, Mancino M, Manfrini N, et al. Role of microRNAs in translation regulation and cancer. World J Biol Chem 2017;8(1):45–56. DOI: 10.4331/wjbc.v8.i1.45
  28. Peng X, Mo Y, Liu J, et al. Identification and validation of miRNA-TF-mRNA regulatory networks in uterine fibroids. Front Bioeng Biotechnol 2022;10:856745. DOI: 10.3389/fbioe.2022.856745
  29. Ciebiera M, Włodarczyk M, Zgliczyński S, et al. The role of miRNA and related pathways in pathophysiology of uterine fibroids-from bench to bedside. Int J Mol Sci 2020;21(8):3016. DOI: 10.3390/ijms21083016
  30. Włodarczyk M, Nowicka G, Ciebiera M, et al. Epigenetic regulation in uterine fibroids—the role of ten-eleven translocation enzymes and their potent application. Int J Mol Sci 2022;23(5):2720. DOI: 10.3390/ijms23052720
  31. Nusair B, Al-Gudah M, Chodankar R, et al. Uterine fibroid mapping. Curr Obstet Gynecol Rep 2016;5(2):73–80. DOI: 10.1007/s13669-016-0154-2
  32. Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update 2016;22(6): 665–686. DOI: 10.1093/humupd/dmw023
  33. Palheta MS, Medeiros FDC, Severiano ARG. Reporting of uterine fibroids on ultrasound examinations: an illustrated report template focused on surgical planning. Radiol Bras 2023;56(2):86–94. DOI: 10.1590/0100-3984.2022.0048
  34. Ahmadi F, Hosseini F, Javam M, et al. Hysterosalpingography findings of leiomyomas and how they look in artistic eyes: new diagnostic signs. Br J Radiol 2021;94(1121):20200019. DOI: 10.1259/bjr.20200019
  35. Kim YJ, Kim YY, Shin JH, et al. Variation in MicroRNA expression profile of uterine leiomyoma with endometrial cavity distortion and endometrial cavity non-distortion. Int J Mol Sci 2018;19(9):2524. DOI: 10.3390/ijms19092524
  36. Moshesh M, Peddada SD, Cooper T, et al. Intraobserver variability in fibroid size measurements: estimated effects on assessing fibroid growth. J Ultrasound Med 2014;33(7): 1217–1224. DOI: 10.7863/ultra.33.7.1217
  37. Kolterud Å, Välimäki N, Kuisma H, et al. Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate. Hum Mol Genet 2023;32(7):1063–1071. DOI: 10.1093/hmg/ddac217
  38. Gloria-Bottini F, Neri A, Pietropolli A, et al. Significant relationship of combined ACP1/PTPN22 genotype variants with the growth of uterine leiomyomas. Taiwan J Obstet Gynecol 2018;57(4):567–569. DOI: 10.1016/j.tjog.2018.06.017
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.